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Biotechnology is the application of biological techniques to develop new tools and products for medicine and industry.  Due to various 
properties including chemical stability, biocompatibility, and specific activity, e.g. antimicrobial properties, many new and novel 
materials are being investigated for use in biosensing, drug delivery, hemodialysis, and other medical applications.  Many of these 
materials are less than 100 nanometers in size. Nanotechnology is the engineering discipline encompassing designing, producing, testing, 
and using structures and devices less than 100 nanometers.  One of the challenges associated with biomaterials is microbial 
contamination that can lead to infections.  In recent work we have examined the functionalization of nanoporous biomaterials and 
antimicrobial activities of nanocrystalline diamond materials.  In vitro testing has revealed little antimicrobial activity against 
Pseudomonas fluorescens bacteria and associated biofilm formation that enhances recalcitrance to antimicrobial agents including 
disinfectants and antibiotics.  Laser scanning confocal microscopy studies further demonstrated properties and characteristics of the 
material with regard to biofilm formation.   
 
Introduction 
In recent years the development of nanotechnology has 
allowed the development of new materials to combat 
microbial biofilm formation on biomaterials. These advances 
in the use of nanostructured materials for medical applications 
have resulted from two primary considerations. First, there is 
a natural evolution to nanoscale materials as novel processing, 
characterization, modeling techniques, and technology for 
necessary manipulation and manufacturing becomes available. 
Second, specific interactions between biological structures 
(e.g., tissues and other cellular processes) and nanostructured 
materials may allow for devices with specific functionalities 
to be developed. 
     Nanocrystalline diamond has recently been considered for 
use in preventing microbial growth (Leis et al., 2010).  
Diamondlike carbon-silver, diamondlike carbon-platinum, and 
diamondlike carbon-silver-platinum composite films have 
been prepared using a novel multicomponent target pulsed 
laser deposition process11. Silver and platinum form 
nanoparticle arrays within the diamondlike carbon matrix that 
can be attributed to the high surface energy of noble metals 
relative to carbon.  Diamondlike carbon-silver-platinum 
composites exhibit significant antimicrobial efficacy against 
Staphylococcus bacteria11. Robust antimicrobial function has 
been observed in diamondlike carbon-silver-platinum 
composite films; this functionality is tentatively attributed to 
the formation of a galvanic couple between silver and 
platinum that enhances silver ion release12.  Diamondlike 
carbon-metal composite films may provide higher hardness, 
corrosion resistance, and antimicrobial functionalities to next 
generation cardiovascular, orthopaedic, biosensor, and other 
biomedical devices.  New applications of the antimicrobial 
properties of diamond-like carbon-silver-platinum 
nanocomposites may include catheters and other devices14. 
   Novel antimicrobial silver ion complex resinate 
compositions comprising a silver-thiosulfate ion complex 
loaded onto an organic anion exchange resin have been 
proven successful2. These silver thiosulfate ion complex 
resinate compositions are able to release stable antimicrobial 
silver ion complexes over time when placed in a saline 
environment. These antimicrobial silver-ion complex 
resinates can be useful in the treatment and prevention of 
infections and diseases. 
   A stabilized composition having antibacterial, antiviral 
and/or antifungal activity utilizing a silver compound in the 
form of a complex with primary, secondary or tertiary amines 
has also proven effective for use in urine catheters (Pedersen; 
et al., 2002).  The complex is associated to one or more 
hydrophilic polymers, remains stable during sterilization, and 
retains antimicrobial activity without giving rise to darkening 
or discoloration of the dressing during storage.  An 
antimicrobial latex composition comprising a homogeneous 
blend of a natural/synthetic rubber latex and protein silver, 
and a second antimicrobial latex composition comprising a 
homogeneous blend of a cationic natural rubber latex or a 
cationic synthetic polymer latex and a water-soluble silver 
compound has also been developed16. 
   Atomic layer deposition (also known as molecular layering 
or atomic layer epitaxy) is a thin film growth technique in 
which alternating controlled surface chemical reactions occur 
between gaseous precursor molecules14. The self-terminating 
gas-solid reactions allow for material to be applied in a 
layered methodology.  Individual reactions are separated by 
purge steps that involve saturation with an inert gas. By 
saturating the substrate at each individual reaction, all 
surfaces of a given substrate can receive a uniform coating of 
thickness and composition. The atomic layer deposition 
cycles can be repeated to control precisely the coating 
thickness of any applied inorganic antimicrobial agent at the 
nano scale including TiO14. 
   Atomic layer deposition has also been used to coat the 
surfaces of proposed biomaterials including nanoporous 
alumina membrane in order to reduce the pore size in a 
controlled manner4. Recent work on unmodified nanoporous 
alumina membranes has shown that release of biological 
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molecules in nanoporous alumina membranes is determined 
by the diameters of the pores9. Narayan et al., 2009, 
demonstrated that titanium oxide (TiO) coating can reduce the 
pore size in a controlled manner, maintain a narrow pore size 
distribution, prevent aluminum ions from leaching into the 
surrounding tissues, and create a biocompatible antimicrobial 
pore/tissue interface under the right conditions.  In that work 
microbial results showed a significant decrease in the amount of 
microbial attachment to membranes treated with TiO with both 
Staphylococcus  aureus and  Escherichia  coli.  
   Biofilm are aggregates of microorganisms in which cells adhere 
to each other and/or to a surface. The associated cells are 
frequently embedded within a self-produced matrix of 
extracellular polymeric substance (EPS). Biofilm EPS is a 
polymeric conglomeration generally composed of extracellular 
DNA, proteins, and polysaccharides that can become highly 
organized, making it resistant to biocides. Biofilms may form on 
living or non-living surfaces, and represent a prevalent mode of 
microbial life in natural, industrial and hospital settings1.  
  Biofilm formation in medical devices is inherently disruptive as 
it can lead to health concerns including infection 7. All novel 
biomaterial for use in medical devices must be tested to 
determine their resistance to biofilm development.  In this study, 
the resistance of nanocrystalline diamond to growth of microbial 
biofilms in a continuous perfusion environment was examined. 
 
Materials and Methods 
 
CDC Bioreactors: A rotating disc reactor CDC biofilm reactor 
(Biosurface Technologies, Bozeman, MT, USA) containing 
silicon, silica glass, roughened silica glass, nanocomposite 
samples fixed to silica glass, and coated polycarbonate circular 
samples was used for microbial testing.  The CDC biofilm 
bioreactor and all operating components were autoclaved prior to 
the testing. This CDC reactor consists of a 1-L vessel with an 
effluent spout at approximately 400 ml, which is connected to a 
waste bottle. Continuous mixing of the bulk fluid is ensured by a 
magnetically driven (RET digi-visc, IKA Labortechnik, 
Wilmington, MA, USA) baffled stir bar. A polyethylene lid 
supports eight independent rods, which each can house three 
removable circular disks. The lid also contains three stainless 
steel ports allowing the connection of two sterile (0.2 µm) vent 
filters (Millex®-FG, Millipore, Bedford, MA, USA) and an inlet 
for the diluted growth medium. All materials and growth medium 
were autoclaved prior to use. Low concentrations (1%) of 
Peptone-Trypticase-Yeast extract-Glucose (PTYG) medium was 
used3 as the growth medium.  Initially, reactors were operated in 
batch mode for 24 h to establish the biofilms on the various 
substrata in 1% PTYG medium. Following the period of batch 
growth, the system was operated in chemostat mode by 
continuously pumping the 1% PTYG medium Pseudomonas 
fluorescens flow rate of 2 ml/min for 72 h.  
   The nanocrystalline diamond material was described previously 
by Lewis et al10.  Briefly, the nanocrystalline diamond samples 
were mounted on coupons on the rotating disc of the reactor. 
 
Pseudomonas fluorescens (strain #B252) was the biofilm forming 
microorganism tested  as previously described10. List of materials 
including controls placed in CDC biofilm bioreactor is as follows 
1. Frosted glass 
2. Clear Glass 
3. Nanocrystalline diamond 
4. Half nanocrystalline diamond, half smooth. 
5. Control-coupon only-no material. 
 
 
 
Bioreactor Sampling 
 
Coupon samples were removed at the three time points along 
with 4-1 ml aliquots of medium were aseptically removed at the 
following time points 
Time 0 – 1 ml Liquid 
Time 1-1h 25 min Liquid +coupons 
Time 2- 18h 10 min Liquid+coupons 
Time 3-24h 10 min Liquid+coupons 
All samples were immediately frozen @ -20ºC for later analysis.  
The bioreactor was maintained and mixed the entire test in a 
sterile lab hood @ 25°C.   
 
Microbial Analysis 
 
Bacteria densities were determined by Acridine Orange Direct 
Counts (AODC) as previously described 3. 
   Digital mages of the stained cells on the coupons and materials 
were obtained using a laser confocal scanning microscope 
(Model LSM 510  Carl Zeiss Inc., Germany). Coupon samples 
were thawed, air dried in a sterile laminar flow hood, and then 
stained with 4, 6 diamidino-2-phenylindole (DAPI) to determine 
total microbial cells per microscopic field (Kastner et al., 2000).  
Images of the stained cells were obtained using a laser confocal 
scanning microscope (Model LSM 510 Zeiss, Germany).   
 
Results 
 
P. fluorescens densities in the Bioreactor medium ranged from 
2.98 X 105 cells/ml at Time 0 to 1.56 X 105 cells/ml at Time 3. 
Flow though rate of medium was maintained at 2 ml/minute At 
sampling time 1 after one hour and twenty-five minutes there was 
little difference observed between the controls (frosted glass, 
clear glass, coupon, and half coupon only) and the diamond 
material so far as microbial attachment.  All samples had some P. 
fluorescens cells attached as demonstrated by the LSCM image 
in Figure 1.  The cells attach although the CDC bioreactor is 
constantly swirling the individual coupon holders.  Some cells 
can be observed elongating and dividing indicating early biofilm 
formation.  Note the orientation of the attached on the surface in 
Figure 1.   
 
 
Fig. 1 Attachment of Pseudomonas fluorescens cells mounted on coupon 
with transect showing scale after 1 hour 25 minutes.  
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At sampling time two, 18 hours and ten minutes after continuous 
exposure, biofilm was covering most of the control surfaces. 
Growth of P.  fluorescens demonstrated partial coverage of the 
nanocrystalline diamond  as shown in the LSCM image in Figure 
2. The biofilm was up to 8 µm thick in some areas while others 
sections there was little growth.  Note the cross-bridging 
occurring in Figure 2 (arrow).  Once the two larger clumps of 
cells shown here are ‘tethered’ in this manner they will form 
larger biofilms. This demonstrates the biofilm as it grows in 
organization and structure.  As the density of the biofilm 
increases so does the recalcitrance of the microbial cells on the 
inner layers to drug and/or biocide treatment such as antibiotics.   
Biofilm formation is also resistance to the body’s natural 
immunological defenses such as antibody production and or 
macrophage activity. 
   P. fluorescens colonization on nanocrystalline diamond coating 
after 24 hr incubation was examined using a laser scanning 
confocal microscope (Figure 3A).  This image shows a much 
larger more organized biofilm and smaller cell colonies.  This 
particular larger biofilm formation on the slide center is roughly 
40 µm by 60 µm size. The longer side is oriented with the flow of 
the CDC Bioreactor.  Biofilms form with an initial attachment of 
cells that then begin dividing and forming a colony.  Colonization 
allows more cells from the circulating medium to attach and 
grow.  Figure 2 shows apparent attachment between P. 
fluorescens colonies that over time form larger units.   
   Figure 3B is a side three dimensional view of P. fluorescens 
colony and biofilm formation on the nanocrystalline diamond 
surface observed in Figure 3A. Note the depth of the biofilm is 
up to 10 µm indicating robust growth. 
   Growth of P. fluorescens was similar on the nanocrystalline 
diamond as compared to glass controls at all sampling times.  On 
closer observation at 1300X with LSCM the surface of the 
mounted nanocrystalline diamond material appeared rough and 
angular, allowing microbial attachment and/or entrapment and 
subsequent colonization on the glass surface.   
 
 
 
Fig.2 Pseudomonas fluorescens cells forming a biofilm on the 
nanocrystalline diamond material after 18 hour 10 minutes.  
 
 
 
Discussion 
 
Lewis et al. recently compared microbial growth on 
nanocrystalline diamond coated silicon wafers that were 
immersed in growth medium containing Pseudomonas 
fluorescens10. The results of that work demonstrated  that 
nanocrystalline diamond coatings of surfaces did not prevent P. 
fluorescens growth under operant conditions .  Another study  
demonstrated that Streptococcus mutans, a microorganism of 
concern in dental-related biofilms, uses a peptide pheromone 
quorum-sensing signal transduction system to stimulate the 
uptake and incorporation of foreign DNA. Experimentally the 
signal peptide can be chemically synthesized and added to 
cultures to stimulate transformation indicating microbial 
adaptation to changing environments in biofilms (Li et al., 2001). 
 
 
 
 
 
Fig. 3A Laser scanning confocal microscope three-dimensional image of 
P. fluorescens on nanocrystalline diamond. The image was taken  after 24 
hr in the reactor.   
 
When there are mixed culture biofilms it may be possible for 
transfer of genetic information including antimicrobial resistance. 
Thus there is the possibility of microbial resistance to new 
surface treatment stategies.  The pathogenesis of many 
orthopaedic infections has been  related to the presence of 
microorganisms in biofilms (Patel, 2005).   If the nanocrystalline 
diamond material had been milled or made smoother it may have 
changed the results found here.  
 As described in the results the roughed surface of the 
nanocrystalline diamond appeared to aid microbial 
attachment. 
   Quorum sensing is a biochemical signalling process many 
microbial species use to control their metabolism according to 
environmental conditions.  The colony to colony connections 
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obeserved by P. aeruginosa cells in Figure 2 could be due to 
quorum sensing.  Many bacteria use quorum-sensing systems in 
microbial colonies to regulate several physiological properties, 
including the ability to incorporate foreign DNA, tolerate acid, 
biofilm formation, and virulence5. Successful inhibition of 
quorum sensing in a P. aeruginosa biofilm by a halogenated 
furanone compound could lead to novel antimicrobial agents8. 
Either organic compounds such as furanone or inorganic 
nanomaterials like TiO that affect biofilm architecture and 
enhance microbial detachment that lead to a loss of bacterial 
biomass from surfaces would be useful for biomedical 
applications. 
 
 
Fig. 3B. Three dimensional side image of the same field as Fig. 3A of P. 
fluorescens growth on a nanocrystalline diamond coating taken after 24 
hr.  This image shows a biofilm attached to the nanocrystalline diamond 
coating as well as smaller clumps of cells. 
 
Conclusions 
Under these conditions nanocrystalline diamond coatings did not 
inhibit P. fluorescens attachment and biofilm formation in the 
CDC Biofilm Reactor10. It is evident that once initial microbial 
attachment and colonization occurs, subsequent biofilm 
formation is hard to control (Figure 3A & B).   
   Combining potential antimicrobial materials may be necessary 
for optimal biomedical applications.  Additional nanostructured 
materials with titanium and zinc coatings may be useful for 
inhibiting microbial attachment/colonization for certain 
biomedical applications including catheters. Silicon materials are 
associated with less inflammation than polymeric materials that 
are currently used for local drug delivery. In addition, these 
materials may provide greater flexibility in their applications, 
since there are often difficulties when pharmacologic agents and 
polymers are dissolved in a given solvent.  Nanostructured 
materials prepared using atomic layer deposition may also be 
useful for delivering a pharmacologic agent at a precise rate to a 
specific location in the body.  Delivery could be based on the 
pharmacokinetics of the specific agent. These materials may 
serve as the basis for “intelligent” drug delivery systems, 
orthopaedic implants, or self-sterilizing medical and veterinary 
devices. 
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